SCHEMBL9364462

SCHEMBL9364462

COc1ccc2c(c1)CCC2(C#N)O[Si](C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 3/20 0.43
KDM1A O60341 1/20 0.43
KDM4E B2RXH2 1/20 0.41
JAK2 O60674 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
CYP3A4 P08684 1/20 0.38
DRD2 P14416 1/20 0.37
DRD1 P21728 1/20 0.37
DRD5 P21918 1/20 0.37
DRD3 P35462 1/20 0.37
OTUD7B Q6GQQ9 1/20 0.37
HTR5A P47898 3/20 0.37
KMT2A Q03164 1/20 0.36
AR P10275 2/20 0.36
ADRB2 P07550 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2B P18089 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570951 0.92 KDM1A (0.50) ADRA2AKDM1AKDM4EJAK2ALDH1A1
SCHEMBL8635505 0.92 ALDH1A1 (0.41) ADRA2AKDM4EJAK2ALDH1A1HPGD
SCHEMBL23891554 0.84 ADRA2A (0.38) ADRA2AKDM4EJAK2ALDH1A1HPGD
SCHEMBL6568601 0.84 KDM1A (0.41) KDM1AKDM4EJAK2ALDH1A1HPGD
SCHEMBL1530577 0.83 BACE1 (0.35) KDM1AKDM4EJAK2ALDH1A1HPGD
SCHEMBL7980930 0.83 KDM1A (0.37) KDM1A
SCHEMBL1570433 0.80 APP (0.35) KDM4EJAK2ALDH1A1HPGDDRD2
SCHEMBL7973198 0.80 KDM1A (0.36) KDM1AALDH1A1KMT2ASIGMAR1
SCHEMBL10469737 0.77 OPRM1 (0.33) ADRA2AKDM4EALDH1A1OTUD7BHTR5A
SCHEMBL17605796 0.76 ALDH1A1 (0.41) ADRA2AKDM4EALDH1A1OTUD7BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0275104-B1 Process for preparing 2,3-dihydro-1H-imidazolylalkoxyindene derivatives and pharmaceutically acceptable salts, and intermediate therefor FERRER INT (ES) 1994-01-19 EP disclosed
EP-0275104-A2 Process for preparing 2,3-dihydro-1H-imidazolylalkoxyindene derivatives and pharmaceutically acceptable salts, and intermediate therefor FERRER INTERNACIONAL, S.A. (ES) 1988-07-20 EP disclosed